Identification of ALK and ROS1 fusion proteins in non-small cell lung cancer (NSCLC) at Cell Signaling Technology (CST).
Cancer signaling pathways and research resources, including activation state antibodies and proteomic tools to discover post-translational modifications
Immunohistochemistry Protocol (Paraffin): easy to follow directions describing the step by step experimental procedure.
An outline and examples of the steps performed at Cell Signaling Technology to validate target specificity of an antibody for use in immunohistochemical analysis.
PTMScan Technology enables biomarker discovery and signaling regulation by combining enrichment of post-translational modifications with mass spectrometry.
Listing of IHC-related scientific posters and papers involving scientists from Cell Signaling Technology.
List of publications based on primary research done by the Cancer Research Group at CST (2002-2013).
A list of recommended cell types and treatments to be used as positive and negative controls for activation state specific antibodies
